Global Radioactive Stent Used for Cancer Treatments Market Insights, Research, Forecast to 2025

Published On: Aug 2019

Format: PDF

Publisher: QY Research

Pages: 117

Report ID: 347718

Radioactive stent, the self-expanding stent with radioactivity particles is regards as very useful in the treatment of medium and advanced esophageal cancer.
Jiangsu Province is the largest suppling place as the top 3 manufacturers are located therem Micro-Tech, Changzhou Zhiye and Changzhou Garson. In 2016, Jiangsu Province occupied market share above 88%.
Now, Radioactive Stent are still mainly used in the Esophageal Cancer Therapy. While many scientists and doctors are expanding its application on other cancer therapy.
The global Radioactive Stent Used for Cancer Treatments market is valued at 2 million US$ in 2018 and will reach 3 million US$ by the end of 2025, growing at a CAGR of 6.2% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Radioactive Stent Used for Cancer Treatments market based on company, product type, end user and key regions.

This report studies the global market size of Radioactive Stent Used for Cancer Treatments in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Radioactive Stent Used for Cancer Treatments in these regions.
This research report categorizes the global Radioactive Stent Used for Cancer Treatments market by top players/brands, region, type and end user. This report also studies the global Radioactive Stent Used for Cancer Treatments market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Micro-Tech
Changzhou Zhiye
Changzhou Garson

Market size by Product
18mm Stent
20mm Stent
14mm Stent
Other Stents
Market size by End User
Esophageal Cancer
Biliary Cancer
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Radioactive Stent Used for Cancer Treatments market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Radioactive Stent Used for Cancer Treatments market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Radioactive Stent Used for Cancer Treatments companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Radioactive Stent Used for Cancer Treatments submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Radioactive Stent Used for Cancer Treatments are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (Unit). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Radioactive Stent Used for Cancer Treatments market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Radioactive Stent Used for Cancer Treatments Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Radioactive Stent Used for Cancer Treatments Market Size Growth Rate by Product
1.4.2 18mm Stent
1.4.3 20mm Stent
1.4.4 14mm Stent
1.4.5 Other Stents
1.5 Market by End User
1.5.1 Global Radioactive Stent Used for Cancer Treatments Market Size Growth Rate by End User
1.5.2 Esophageal Cancer
1.5.3 Biliary Cancer
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Radioactive Stent Used for Cancer Treatments Market Size
2.1.1 Global Radioactive Stent Used for Cancer Treatments Revenue 2014-2025
2.1.2 Global Radioactive Stent Used for Cancer Treatments Sales 2014-2025
2.2 Radioactive Stent Used for Cancer Treatments Growth Rate by Regions
2.2.1 Global Radioactive Stent Used for Cancer Treatments Sales by Regions
2.2.2 Global Radioactive Stent Used for Cancer Treatments Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Radioactive Stent Used for Cancer Treatments Sales by Manufacturers
3.1.1 Radioactive Stent Used for Cancer Treatments Sales by Manufacturers
3.1.2 Radioactive Stent Used for Cancer Treatments Sales Market Share by Manufacturers
3.1.3 Global Radioactive Stent Used for Cancer Treatments Market Concentration Ratio (CR5 and HHI)
3.2 Radioactive Stent Used for Cancer Treatments Revenue by Manufacturers
3.2.1 Radioactive Stent Used for Cancer Treatments Revenue by Manufacturers (2014-2019)
3.2.2 Radioactive Stent Used for Cancer Treatments Revenue Share by Manufacturers (2014-2019)
3.3 Radioactive Stent Used for Cancer Treatments Price by Manufacturers
3.4 Radioactive Stent Used for Cancer Treatments Manufacturing Base Distribution, Product Types
3.4.1 Radioactive Stent Used for Cancer Treatments Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Radioactive Stent Used for Cancer Treatments Product Type
3.4.3 Date of International Manufacturers Enter into Radioactive Stent Used for Cancer Treatments Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Radioactive Stent Used for Cancer Treatments Sales by Product
4.2 Global Radioactive Stent Used for Cancer Treatments Revenue by Product
4.3 Radioactive Stent Used for Cancer Treatments Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Radioactive Stent Used for Cancer Treatments Breakdown Data by End User

6 North America
6.1 North America Radioactive Stent Used for Cancer Treatments by Countries
6.1.1 North America Radioactive Stent Used for Cancer Treatments Sales by Countries
6.1.2 North America Radioactive Stent Used for Cancer Treatments Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Radioactive Stent Used for Cancer Treatments by Product
6.3 North America Radioactive Stent Used for Cancer Treatments by End User

7 Europe
7.1 Europe Radioactive Stent Used for Cancer Treatments by Countries
7.1.1 Europe Radioactive Stent Used for Cancer Treatments Sales by Countries
7.1.2 Europe Radioactive Stent Used for Cancer Treatments Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Radioactive Stent Used for Cancer Treatments by Product
7.3 Europe Radioactive Stent Used for Cancer Treatments by End User

8 Asia Pacific
8.1 Asia Pacific Radioactive Stent Used for Cancer Treatments by Countries
8.1.1 Asia Pacific Radioactive Stent Used for Cancer Treatments Sales by Countries
8.1.2 Asia Pacific Radioactive Stent Used for Cancer Treatments Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Radioactive Stent Used for Cancer Treatments by Product
8.3 Asia Pacific Radioactive Stent Used for Cancer Treatments by End User

9 Central & South America
9.1 Central & South America Radioactive Stent Used for Cancer Treatments by Countries
9.1.1 Central & South America Radioactive Stent Used for Cancer Treatments Sales by Countries
9.1.2 Central & South America Radioactive Stent Used for Cancer Treatments Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Radioactive Stent Used for Cancer Treatments by Product
9.3 Central & South America Radioactive Stent Used for Cancer Treatments by End User

10 Middle East and Africa
10.1 Middle East and Africa Radioactive Stent Used for Cancer Treatments by Countries
10.1.1 Middle East and Africa Radioactive Stent Used for Cancer Treatments Sales by Countries
10.1.2 Middle East and Africa Radioactive Stent Used for Cancer Treatments Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Radioactive Stent Used for Cancer Treatments by Product
10.3 Middle East and Africa Radioactive Stent Used for Cancer Treatments by End User

11 Company Profiles
11.1 Micro-Tech
11.1.1 Micro-Tech Company Details
11.1.2 Company Business Overview
11.1.3 Micro-Tech Radioactive Stent Used for Cancer Treatments Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Micro-Tech Radioactive Stent Used for Cancer Treatments Products Offered
11.1.5 Micro-Tech Recent Development
11.2 Changzhou Zhiye
11.2.1 Changzhou Zhiye Company Details
11.2.2 Company Business Overview
11.2.3 Changzhou Zhiye Radioactive Stent Used for Cancer Treatments Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Changzhou Zhiye Radioactive Stent Used for Cancer Treatments Products Offered
11.2.5 Changzhou Zhiye Recent Development
11.3 Changzhou Garson
11.3.1 Changzhou Garson Company Details
11.3.2 Company Business Overview
11.3.3 Changzhou Garson Radioactive Stent Used for Cancer Treatments Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Changzhou Garson Radioactive Stent Used for Cancer Treatments Products Offered
11.3.5 Changzhou Garson Recent Development

12 Future Forecast
12.1 Radioactive Stent Used for Cancer Treatments Market Forecast by Regions
12.1.1 Global Radioactive Stent Used for Cancer Treatments Sales Forecast by Regions 2019-2025
12.1.2 Global Radioactive Stent Used for Cancer Treatments Revenue Forecast by Regions 2019-2025
12.2 Radioactive Stent Used for Cancer Treatments Market Forecast by Product
12.2.1 Global Radioactive Stent Used for Cancer Treatments Sales Forecast by Product 2019-2025
12.2.2 Global Radioactive Stent Used for Cancer Treatments Revenue Forecast by Product 2019-2025
12.3 Radioactive Stent Used for Cancer Treatments Market Forecast by End User
12.4 North America Radioactive Stent Used for Cancer Treatments Forecast
12.5 Europe Radioactive Stent Used for Cancer Treatments Forecast
12.6 Asia Pacific Radioactive Stent Used for Cancer Treatments Forecast
12.7 Central & South America Radioactive Stent Used for Cancer Treatments Forecast
12.8 Middle East and Africa Radioactive Stent Used for Cancer Treatments Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Radioactive Stent Used for Cancer Treatments Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer